Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 1,399 | $162.08 | $226,749.92 |
DisclosureSEC source: 0001225208-23-001905 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,693 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:35 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 3,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001905 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 2,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001906 · doc4.xml · derivative · entry 5 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,999 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 823 | $162.08 | $133,391.84 |
DisclosureSEC source: 0001225208-23-001906 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,988.9545 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 2,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001906 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,811.9545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionRestricted Share Units · Derivative | 3,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001907 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 1,289 | $162.08 | $208,921.12 |
DisclosureSEC source: 0001225208-23-001907 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,737.001 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 3,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001907 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,026.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 979 | $162.08 | $158,676.32 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,282.204 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:36 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001908 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,261.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionRestricted Share Units · Derivative | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001909 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 667 | $162.08 | $108,107.36 |
DisclosureSEC source: 0001225208-23-001909 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,450.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001909 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,117.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 5,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001910 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 2,267 | $162.08 | $367,435.36 |
DisclosureSEC source: 0001225208-23-001910 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,673 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:37 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 5,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001910 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 148,538 | $72.54 Strike: $72.54 | $10,774,946.52 |
DisclosureSEC source: 0001225208-23-000734 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 148,538 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 98,795 | $173.43 | $17,134,016.85 |
DisclosureSEC source: 0001225208-23-000734 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,720 F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 148,538 | $72.54 | $10,774,946.52 |
DisclosureSEC source: 0001225208-23-000734 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Gorsky AlexDirector
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 547,692 | $72.54 Strike: $72.54 | $39,729,577.68 |
DisclosureSEC source: 0001225208-23-000735 · doc4.xml · derivative · entry 5 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 547,692 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Gorsky AlexDirector
|
Tax withholdingCommon Stock | 366,610 | $173.43 | $63,581,172.30 |
DisclosureSEC source: 0001225208-23-000735 · doc4.xml · nonDerivative · entry 2 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,583.671 F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on the Form 4. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:39 UTC |
Gorsky AlexDirector
|
Exercise / conversionCommon Stock | 547,692 | $72.54 | $39,729,577.68 |
DisclosureSEC source: 0001225208-23-000735 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,133,193.671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 12,926 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · derivative · entry 9 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,926 shares Expires 2024-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 1,855 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · derivative · entry 8 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,855 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 12,926 | $179.62 | $2,321,755.19 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,812.204 F1 · price: This transaction was executed in multiple trades at prices ranging from $179.610 to $179.670. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
SaleCommon Stock | 1,855 | $179.46 | $332,905.72 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,738.204 Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,855 | $72.54 | $134,561.70 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,593.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:34 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 12,926 | $90.44 | $1,169,027.44 |
DisclosureSEC source: 0001225208-22-012842 · doc4.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,738.204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:45 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 240.466 | $178.70 | $42,971.27 |
DisclosureSEC source: 0001225208-22-012445 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,152.487 Underlying: Common Stock · 240.466 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:45 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 350.743 | $178.70 | $62,677.77 |
DisclosureSEC source: 0001225208-22-012446 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,162.9373 Underlying: Common Stock · 350.743 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 21:45 UTC |
WEINBERGER MARK ADirector
|
GrantDeferred Share Units · Derivative | 241.016 | $178.70 | $43,069.56 |
DisclosureSEC source: 0001225208-22-012447 · doc4.xml · derivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,276.051 Underlying: Common Stock · 241.016 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the business day prior to settlement date). Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:32 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 73,323 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-22-012182 · doc4.xml · derivative · entry 6 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,323 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:32 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
SaleCommon Stock | 71,923 | $175.46 | $12,619,271.54 |
DisclosureSEC source: 0001225208-22-012182 · doc4.xml · nonDerivative · entry 3 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,812.9545 F2 · price: This transaction was executed in multiple trades at prices ranging from $175.040 to $176.010. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:32 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
SaleCommon Stock | 1,400 | $176.09 | $246,529.22 |
DisclosureSEC source: 0001225208-22-012182 · doc4.xml · nonDerivative · entry 2 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,735.9545 F1 · price: This transaction was executed in multiple trades at prices ranging from $176.050 to $176.115. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:32 UTC |
McEvoy AshleyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 73,323 | $72.54 | $5,318,850.42 |
DisclosureSEC source: 0001225208-22-012182 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,135.9545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:44 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 76,923 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-22-011890 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,923 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:44 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
SaleCommon Stock | 76,923 | $176.78 | $13,598,401.79 |
DisclosureSEC source: 0001225208-22-011890 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,456.001 F1 · price: This transaction was executed in multiple trades at prices ranging from $176.525 to $177.190. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:44 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 76,923 | $72.54 | $5,579,994.42 |
DisclosureSEC source: 0001225208-22-011890 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,379.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 21:33 UTC |
Decker Robert JController, CAO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 16,928 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0001225208-22-011805 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,928 shares Expires 2024-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 21:33 UTC |
Decker Robert JController, CAO
|
SaleCommon Stock | 16,928 | $175.00 | $2,962,400.00 |
DisclosureSEC source: 0001225208-22-011805 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 21:33 UTC |
Decker Robert JController, CAO
|
Exercise / conversionCommon Stock | 16,928 | $90.44 | $1,530,968.32 |
DisclosureSEC source: 0001225208-22-011805 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 16,410 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-22-011585 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,410 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
SaleCommon Stock | 16,410 | $173.42 | $2,845,772.97 |
DisclosureSEC source: 0001225208-22-011585 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,310.8735 F1 · price: This transaction was executed in multiple trades at prices ranging from $173.41 to $173.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:47 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 16,410 | $72.54 | $1,190,381.40 |
DisclosureSEC source: 0001225208-22-011585 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,720.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 10,033 | $115.67 Strike: $115.67 | $1,160,517.11 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,033 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 7,010 | $101.87 Strike: $101.87 | $714,108.70 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,010 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 7,010 | $101.87 | $714,108.70 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,176.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:01 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 10,033 | $115.67 | $1,160,517.11 |
DisclosureSEC source: 0001225208-22-011500 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,166.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 21:59 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 16,953 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-22-011458 · doc4.xml · derivative · entry 6 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,953 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.